China Universal Asset Management Company’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-334
| Closed | -$5.27K | – | 490 |
|
|
2023
Q3 | $5.27K | Buy |
334
+162
| +94% | +$2.56K | ﹤0.01% | 387 |
|
|
2023
Q2 | $3.34K | Sell |
172
-5
| -3% | -$97 | ﹤0.01% | 404 |
|
|
2023
Q1 | $5.02K | Buy |
177
+45
| +34% | +$1.28K | ﹤0.01% | 366 |
|
|
2022
Q4 | $3.86K | Buy |
132
+8
| +6% | +$234 | ﹤0.01% | 327 |
|
|
2022
Q3 | $3K | Buy |
+124
| New | +$3K | ﹤0.01% | 340 |
|